Tillotts Pharma UK Limited

Active07186552 Private limited company

Incorporated: 11 March 2010 (16 years)
Industry: Other business support service activities n.e.c. (82990)
Directors: Kelly Maree Little
Adrian Steventon Hill
Lisa Robinson
Owned by: Zeria Pharmaceutical Co.,Ltd
Accounts type: Full
Region: East Midlands
Address: Larbourne Suite The Stables
Wellingore Hall
Wellingore
LN5 0HX

Website & contact details

Website: tillotts.co.uk

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 25 March 2027
Last conf. stmt: 11 March 2026

Officers 5 active

Officer details are public data from the Companies House register.

Little, Kelly Maree

Director · Appointed 11 June 2026

Australian

Born May 1974 (52)

Bird & Bird Company Secretaries Limited

Corporate Secretary · Appointed 19 March 2025

Also at White Circle Ltd, Kai AI UK Limited (proposed for strike-off), Welbar Energy Storage Limited · more companies

Hill, Adrian Steventon

Director · Appointed 19 March 2025

British

Born February 1970 (56)

Robinson, Lisa

Director · Appointed 18 March 2024

British

Born March 1979 (47)

Robinson, Lisa

Secretary · Appointed 16 March 2020

Officer history (11 former)

30 September 2026

Resigned Thorpe, Jeremy as Director

11 June 2026

Appointed Little, Kelly Maree as Director

19 March 2025

Appointed Bird & Bird Company Secretaries Limited as Corporate Secretary

19 March 2025

Appointed Hill, Adrian Steventon as Director

31 August 2024

Resigned Portmann, Marcel Paul as Director

18 March 2024

Appointed Robinson, Lisa as Director

28 February 2024

Resigned Lange, Barbara, Dr as Director

25 March 2022

Appointed Portmann, Marcel Paul as Director

25 March 2022

Resigned Norrman, Olof Mattias as Director

27 March 2020

Appointed Lange, Barbara, Dr as Director

16 March 2020

Resigned Johnson, Helen Louise as Secretary

16 March 2020

Appointed Robinson, Lisa as Secretary

31 October 2019

Resigned Johnson, Helen Louise as Director

1 September 2019

Resigned Eberle, Ingrid as Director

1 April 2019

Appointed Johnson, Helen Louise as Director

2 January 2018

Appointed Eberle, Ingrid as Director

2 January 2018

Resigned Kesch, Yves as Director

3 August 2016

Appointed Johnson, Helen Louise as Secretary

3 August 2016

Resigned Aldbury Secretaries Limited as Corporate Secretary

31 March 2016

Appointed Kesch, Yves as Director

31 March 2016

Resigned Toth Von Kisker, Thomas Alexander as Director

14 May 2013

Appointed Thorpe, Jeremy as Director

29 August 2012

Resigned Cambridge, Allan Charles as Director

11 March 2010

Appointed Toth Von Kisker, Thomas Alexander as Director

11 March 2010

Appointed Aldbury Secretaries Limited as Corporate Secretary

11 March 2010

Appointed Cambridge, Allan Charles as Director

11 March 2010

Appointed Norrman, Olof Mattias as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Zeria Pharmaceutical Co.,Ltd

Corporate entity · Notified 5 March 2024

Owns 75–100% of shares

Holds 75–100% of voting rights

Right to appoint and remove directors

Publicly Traded Company

Reg. no. 0100-01-034790

Financials

Balance sheet as at 31 December 2025 · full accounts

Cash: £9,933,841
Turnover: £62,151,963
Profit Before Tax: £2,846,547
Employees: 41

Current Ratio: 1.4x
Profit Margin: 5%
Return on Equity: 17%

Trend

Turnover

Balance sheet detail

	2025	2024	2023	2022	2021	2020	2019
Current Assets	£45,418,493	£33,560,912	£31,475,606	£34,467,556	£34,770,029	£32,510,966	£15,980,641
Debtors	£25,495,864	£20,771,136	£18,344,721	£9,601,831	£10,830,121	£6,906,151	£6,807,519
Cash	£9,933,841	£7,000,627	£5,511,546	£12,228,580	£6,203,086	£8,031,691	£1,198,496
Creditors (< 1 year)	£32,510,338	£22,787,746	£22,629,332	£26,909,501	£28,444,280	£27,314,801	£11,950,330
Net Current Assets	£12,908,155	£10,773,166	£8,846,274	£7,558,055	£6,325,749	£5,196,165	£4,030,311
Shareholder Funds	£12,908,155	£10,773,166	£8,846,274	£7,558,055	£6,325,749	£5,196,165	£4,030,311

Turnover	£62,151,963	£57,780,298	£53,899,030	£44,536,181	£38,028,939	£34,553,774	£29,311,243
Cost of Sales	£52,534,200	£46,690,674	£43,143,707	£33,664,220	£29,367,878	£27,176,828	£21,378,956
Gross Profit	£9,617,763	£11,089,624	£10,755,323	£10,871,961	£8,661,061	£7,376,946	£7,932,287
Admin Expenses	£9,226,071	£8,497,974	£8,341,797	£8,901,640	£6,975,864	£6,112,806	£6,690,902
Staff Costs	£4,233,984	£4,047,774	£3,776,803	£4,038,959	£3,266,133	£2,935,862	£2,768,197
Operating Profit	£2,889,372	£2,595,972	£2,414,126	£1,971,971	£1,708,307	£1,468,439	£1,260,721
Profit Before Tax	£2,846,547	£2,567,210	£1,692,090	£1,521,322	£1,394,941	£1,439,734	£873,233
Tax	£711,558	£640,318	£403,871	£289,016	£265,357	£273,880	£165,852
Profit for Period	£2,134,989	£1,926,892	£1,288,219	£1,232,306	£1,129,584	£1,165,854	£707,381

Filings 77

Date	Description	Made Up To
30 September 2026	Termination of appointment of a director
2 July 2026	Appointment of a director
24 April 2026	Full accounts	31 December 2025
26 March 2026	Confirmation statement with no updates	11 March 2026
8 April 2025	Full accounts	31 December 2024